+433.2%
SNDK vs THC
+46.1%
+387.0%
-56.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -7.9% | +9.6% | -17.5% | -7.5% |
| 7D | -26.2% | +8.8% | -35.0% | -25.8% |
| 30D | -39.1% | +12.6% | -51.8% | -38.8% |
| 3M | -27.3% | +15.4% | -42.7% | -26.8% |
| 6M | -17.4% | +57.7% | -75.1% | -23.6% |
| YTD | +337.0% | +47.1% | +290.0% | +318.3% |
| 1Y | +433.2% | +40.7% | +392.5% | +434.0% |
| All | +433.2% | +46.1% | +387.0% | +434.0% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling